After all, plasmalemmal expression of type-1 VDAC can be understood. Phosphorylation, nitrosylation, and channel modulators work together in vertebrate cell volume regulation and either apoptotic pathway by Friedrich P. Thinnes
OPINION
published: 27 April 2015
doi: 10.3389/fphys.2015.00126
Frontiers in Physiology | www.frontiersin.org 1 April 2015 | Volume 6 | Article 126
Edited by:
Ali Mobasheri,
University of Surrey, UK
Reviewed by:
Pablo Martin-Vasallo,
Universidad de La Laguna, Spain
*Correspondence:
Friedrich P. Thinnes,
Max-Planck-Gesellschaft München,
Baumschulenwe 5, D-37083
Göttingen, Germany
Website: http://www.futhin.de
futhin@t-online.de
Specialty section:
This article was submitted to
Membrane Physiology and Membrane
Biophysics,
a section of the journal
Frontiers in Physiology
Received: 05 February 2015
Accepted: 07 April 2015
Published: 27 April 2015
Citation:
Thinnes FP (2015) After all,
plasmalemmal expression of type-1
VDAC can be understood.
Phosphorylation, nitrosylation, and
channel modulators work together in
vertebrate cell volume regulation and
either apoptotic pathway.
Front. Physiol. 6:126.
doi: 10.3389/fphys.2015.00126
After all, plasmalemmal expression
of type-1 VDAC can be understood.
Phosphorylation, nitrosylation, and
channel modulators work together in
vertebrate cell volume regulation and
either apoptotic pathway
Friedrich P. Thinnes*
Max-Planck-Gesellschaft München, Göttingen, Germany
Keywords: porin, VRAC, VSOAC, IClswell, cystic fibrosis, Alzheimer’s Disease, malaria, autism
Introduction
Since the beginning of VDAC’s history in 1976 artificial lipid bilayer studies of native (Schein
et al., 1976; Benz et al., 1992; Colombini and Mannella, 2012) and recombinant (Bayrhuber
et al., 2008; Hiller et al., 2008; Ujwal et al., 2008; Teijido et al., 2012) VDAC preparations are
used to operationally define differing states of VDAC channel regulation. Up to near past just
one fully open and a series of partially closed states have been stated. Since 1989, human type-
1 VDAC was shown to reside in the plasmalemma of mammalian cells, a fully closed VDAC-1
state has been postulated, putatively achieved by interactions with proteineous modulators, low
molecular weight agonists, or posttranslational protein modifications, as there are acetylation,
phosphorylation, and nitrosylation (Thinnes and Reymann, 1997; Thinnes, 2013). Correspond-
ingly, three differing VDAC states are discussed in recent structural studies on type-1 verte-
brate VDAC using varying biophysical or in silico approaches (Bayrhuber et al., 2008; Hiller
et al., 2008; Ujwal et al., 2008; Teijido et al., 2012). These are: (1) open = anion-selective = N-
terminal stretch of AA 1-25 inside the barrel; (2) partially closed = cation-selective = N-terminal
stretch of AA 1-25 inside the barrel but in differing position; (3) fully closed = collapsed =
impermeable for ions or flickering = N-terminal stretch outside the β-barrel and accessible for
antibodies.
Phosphorylation of VDAC-1 of Cell in Culture Helps Understand
Conductance Switches Induced by Amyloid Aβ
Fernandez-Echevarria et al. (2014) summarize their recent study linking regulation of
plasmalemma-standing VDAC-1 and the etiology of Alzheimer’s Disease as follows:
“Voltage-dependent anion channel (VDAC) is a mitochondrial protein abundantly found in
neuronal lipid rafts. In these membrane domains, VDAC is associated with a complex of signaling
proteins that trigger neuroprotective responses. Loss of lipid raft integrity may result in disruption
of multicomplex association and alteration of signaling responses that may ultimately promote
VDAC activation. Some data have demonstrated that VDAC at the neuronal membrane may be
involved in the mechanisms of amyloid beta (Aβ)-induced neurotoxicity, through yet unknown
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mechanisms. Aβ is generated from amyloid precursor protein
(APP), and is released to the extracellular space where it may
undergo self-aggregation. Aβ aggregate deposition in the form
of senile plaques may lead to Alzheimer’s disease (AD) neu-
ropathology, although other pathological hallmarks (such as
hyper-phosphorylated Tau deposition) also participate in this
neurodegenerative process. The present study demonstrates that
VDAC1 associates with APP and Aβ in lipid rafts of neurons.
Interaction of VDAC1 with APP was observed in lipid rafts from
the frontal and entorhinal cortex of human brains affected by AD
at early stages (I-IV/0-B of Braak and Braak). Furthermore, Aβ
exposure enhanced the dephosphorylation of VDAC1 that corre-
lated with cell death. Both effects were reverted in the presence of
tyrosine phosphatase inhibitors. VDAC1 dephosphorylation was
corroborated in lipid rafts of AD brains. These results demon-
strate that Aβ is involved in alterations of the phosphorylation
state of VDAC in neuronal lipid rafts. Modulation of this chan-
nel may contribute to the development and progression of AD
pathology.”
From my point of view this study marks a break through to
understand the incorporation of VDAC-1 into cell membranes.
For a recent review on VDAC phosphorylation concerning the
cell fate see (Martel et al., 2014).
Nitrosation of VDAC-1 is Critical for
Blocking the Channel in Fully Closed or
Flickering State
Tewari et al. (2015) by a combination of black membrane mea-
surements of recombinant VDAC-1 and in silico work quite
recently elaborated the relevance of nitrosation for blocking
VDAC-1 in its closed state. While the authors discuss their data
only in the context of mitochondria-standing VDAC-1, I read
them as supporting the plasmalemmal expression of VDAC-1.
They summarize their work by: “The VDAC is the main
conduit for permeation of solutes (including nucleotides and
metabolites) of up to 5 kDa across the mitochondrial outer mem-
brane (MOM). Recent studies suggest that VDAC activity is regu-
lated via post-translational modifications (PTMs). Yet the nature
and effect of these modifications is not understood. Herein, sin-
gle channel currents of wild-type, nitrosated, and phosphory-
lated VDAC are analyzed using a generalized continuous-time
Markov chain Monte Carlo (MCMC) method. This developed
method describes three distinct conducting states (open, half-
open, and closed) of VDAC activity. Lipid bilayer experiments
are also performed to record single VDAC activity under un-
phosphorylated and phosphorylated conditions, and are analyzed
using the developed stochastic search method. Experimental data
show significant alteration in VDAC gating kinetics and con-
ductance as a result of PTMs. The effect of PTMs on VDAC
kinetics is captured in the parameters associated with the identi-
fiedMarkovmodel. Stationary distributions of theMarkovmodel
suggest that nitrosation of VDAC not only decreased its con-
ductance but also significantly locked VDAC in a closed state.
On the other hand, stationary distributions of the model associ-
ated with un-phosphorylated and phosphorylated VDAC suggest
a reversal in channel conformation from relatively closed state to
an open state. Model analyses of the nitrosated data suggest that
faster reaction of nitric oxide with Cys-127 thiol group might be
responsible for the biphasic effect of nitric oxide on basal VDAC
conductance.”
Interaction of Human Plasminogen Kringle
5 and Plasmalemmal VDAC-1 Links the
Channel to the Extrinsic Apoptotic
Pathway
Li et al. (2014) impressively widened knowledge concerning the
proteineous VDAC-1 modulator human plasminogen kringle 5
(K5) by stating that:
“Human plasminogen kringle 5 (K5) is known to display
its potent anti-angiogenesis effect through inducing endothelial
cell (EC) apoptosis, and the voltage-dependent anion channel 1
(VDAC1) has been identified as a receptor of K5. However, the
exact role and underlying mechanisms of VDAC1 in K5-induced
EC apoptosis remain elusive. In the current study, we showed
that K5 increased the protein level of VDAC1, which initiated
the mitochondrial apoptosis pathway of ECs. Our findings also
showed that K5 inhibited the ubiquitin-dependent degradation of
VDAC1 by promoting the phosphorylation of VDAC1, possibly
at Ser-12 and Thr-107. The phosphorylated VDAC1 was atten-
uated by the AKT agonist, glycogen synthase kinase (GSK) 3β
inhibitor, and siRNA, suggesting that K5 increased VDAC1 phos-
phorylation via the AKT-GSK3β pathway. Furthermore, K5 pro-
moted cell surface translocation of VDAC1, and binding between
K5 and VDAC1 was observed on the plasma membrane. HKI
protein blocked the impact of K5 on the AKT-GSK3β pathway
by competitively inhibiting the interaction of K5 and cell surface
VDAC1. Moreover, K5-induced EC apoptosis was suppressed
by VDAC1 antibody. These data show for the first time that
K5-induced EC apoptosis is mediated by the positive feedback
loop of “VDAC1-AKT-GSK3β-VDAC1,” which may provide new
perspectives on the mechanisms of K5-induced apoptosis.”
Again, this study strongly points to plasmalemma-integrated
type-1VDAC and furthermore links the channel to the extrinsic
apoptotic pathway.
Conclusion and Outlook
A series of recent studies, from my point of view, marks great
moments of VDAC research.
(1) From my point of view, the recent studies of Fernandez-
Echevarria et al. (2014), Tewari et al. (2015), and Li
et al. (2014) are well in line with observations on cell
membrane-expression, more precisely plasmalemmal lipid
raft-integration of mammalian VDAC-1. The data on
VDAC-1 posphorylation of cells in culture, this in correla-
tion to channel opening and closing, help understand dif-
fering regulation states even in different compartments, and
they also argue in favor of an involvement in cell volume reg-
ulation and thus apoptosis. The study on VDAC-1 nitrosa-
tion supplements those data by demonstrating its relevance
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FIGURE 1 | Highly schematic two-dimensional projections of human
type-1 VDAC summarising e data from my own lab and the
laboratories of Vito De Pinto, Roland Benz, Varda Shoshan-Barmatz,
Carmen Mannella, and Jeff Abramson for details see Thinnes, 2015.
Fully closed state and open state of native VDAC-1 are compared.
Noteworthy the GxxxG motif, that has been shown to work as an ATP
binding site and may putatively figure as a peptide interaction/membrane
perturbation motif.
for channel closing. The study of Li et al. (Best et al., 2007),
furthermore, puts type-1VDAC another time in touch with
the extrinsic apoptotic pathway. Together, the results help
to functionally understand much evidence indicating that
plasmalemmal VDAC-1 forms the channel part of a volume
regulated anion channel complex (VRAC, ORDIC, VSOR,
Iclswell) that, in terms of molecular identity, still awaits defi-
nition (Dermietzel et al., 1994; Thinnes and Reymann, 1997;
Thinnes et al., 2000; Okada et al., 2004; Elinder et al., 2005;
Thinnes and Burckhardt, 2012; Thinnes, 2013; Akita and
Okada, 2014).
(2) There are increasing data pointing to the medical relevance
of cell membrane-standing VDAC-1 by its involvement in
the pathogenesis of several syndromes, e.g., cancer, cystic
fibrosis, Alzheimer’s Disease, autism, and malaria (Thinnes
and Reymann, 1997; Best et al., 2007; Scharstuhl et al., 2009;
Bouyer et al., 2011; Thinnes, 2013, 2014; Asmarinah et al.,
2014; Shoshan-Barmatz et al., 2014; Tewari et al., 2014;
Weiser et al., 2014; Zhang et al., 2014). These data, from
my point of view, give reason for the request to keep plas-
malemmal VDAC-1 on the schedule in mammalian VDAC
studies.
(3) Concerning the still running dispute on the accessibility of
the N-terminus of VDAC at cell surfaces or outer mito-
chondrial membranes by antisera or monoclonal antibodies,
respectively, Figure 1 (De Pinto et al., 1991; Guo and Man-
nella, 1992; Stanley et al., 1995; Geula et al., 2012; Tomasello
et al., 2013; Huang et al., 2015; Thinnes, 2015). From my
point of view, profit can be taken from an evident difference
between animal and plant VDAC. While animal VDAC-1 at
the proximal end of the free N-terminal peptide stretch car-
ries a GxxxG motif, this motif is missing in plants (Thinnes,
2012). From here it may well pay to elaborate first three-
dimensional structure date on plant VDAC, the more as new
ideas to understand VDAC cell membrane incorporation
may arise (Komarova et al., 2014).
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